
As a leading event in the field, this conference brings together renowned experts, researchers, and healthcare professionals to discuss the latest advancements, research findings, and innovative treatments related to glomerulonephritis.
The 5th Glomerulonephritis Conference, held in 2025, marked a significant milestone in advancing the conversation on GN research and care. Here's a snapshot of its remarkable impact:
The 5th Glomerulonephritis Conference, held in 2025, marked a significant milestone in advancing the conversation on GN research and care. Here's a snapshot of its remarkable impact:
Onsite & Virtual Registrants
Case Submissions
Speakers & Moderators
Hospitals & Organizations
Sponsors & Exhibitors
On behalf of the Emirates Medical Association Nephrology and Transplantation (EMAN-T), we are excited to invite you to the 6th Glomerulonephritis Conference 2026, taking place in Dubai from April 24 to 26.
This conference will gather members of the regional nephrology community, including clinicians, researchers, and other healthcare professionals, who are dedicated to this specialized area of nephrology.
Our goal is to enhance the education of professionals, foster disease research, and improve the quality of healthcare both locally and regionally. Since the inception of EMANT's educational initiatives, we have strived to provide valuable guidance and knowledge to advance nephrology in the UAE.
The Organizing Committee has designed various engaging opportunities for all attendees, enabling physicians and healthcare providers to actively contribute to the improvement of multidisciplinary nephrology care within our community and beyond. We hope you will take full advantage of this opportunity, and we look forward to welcoming you for a memorable and enriching experience at this significant event for the nephrology community.


The 6th Glomerulonephritis Conference will focus on cutting-edge developments across glomerular diseases, including advances in nephropathology, podocytopathies, and autoimmune conditions like lupus nephritis and ANCA-associated vasculitis. Key discussions will cover GN in complex settings such as oncology and kidney transplantation, as well as the impact of immunotherapy on kidney function. The program will also highlight progress in the diagnosis and treatment of membranous nephropathy and IgA nephropathy, complemented by interactive clinical case sessions.
These themes reflect a multidisciplinary approach to GN, integrating pathology, immunology, clinical trials, and real-world management.



HOSTED BY


© 2025 Glomerulonephritis Conference. All rights reserved.